Hints and tips:
...Drug production is a longer-term possibility. Luis Limlingan, managing director at Manila-based brokerage Regina Capital Development, said Ayala’s healthcare investment is promising....
...DoubleDragon’s price-earnings multiple is 100, higher than those of SM Prime and Ayala Land, which are both trading at around 30, noted Luis Limlingan, managing director of Reginal Capital Development....
...A version of this article was first published by the Nikkei Asian Review on June 9. Website | Subscribe. ©2016 Nikkei Inc. All rights reserved....
...OncoTherapy Science rose 4.8 per cent to Y327,000 on the junior Mothers market after it announced plans to start clinical trials for an experimental colon cancer drug....
International Edition